CRI vs DCH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CRI exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a robust current ratio of 2.51, indicating low immediate insolvency risk. While the stock is attractively valued relative to the sector (P/E 14.70 vs 35.14) and trades near its Graham Number of $38.02, it is hampered by a long-term bearish price trend (-55.4% over 5 years) and sluggish earnings growth. The disconnect between strong balance sheet health and poor price performance suggests a value trap scenario unless growth accelerates. Overall, the company is a stable 'Hold' with limited immediate catalysts for a breakout.
DCH exhibits a critical disconnect between valuation and financial health, highlighted by a weak Piotroski F-Score of 2/9 and a concerning Debt/Equity ratio of 6.64. While the stock appears deeply undervalued on a Forward P/E (6.34) and Price/Sales (0.24) basis, the underlying balance sheet is fragile. Strong earnings surprises and a bullish analyst consensus suggest a potential turnaround, but the lack of revenue growth and poor deterministic health scores make this a high-risk speculative play.
Compare Another Pair
Related Comparisons
CRI vs DCH: Head-to-Head Comparison
This page compares Carter's, Inc. (CRI) and Dauch Corporation (DCH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.